Having trouble accessing articles? Reset your cache.

Milagen: Antibodies, quick time

Antibodies have been used as biochemical reagents for more than 50 years, but most of the attention for both reagent and therapeutic use has been on monoclonals. Milagen Inc. is using its expertise in rapidly producing polyclonal antibodies to create tools to identify targets for drug discovery and to find disease biomarkers. The company's goal is to create an antibody to every protein

Read the full 631 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE